Literature DB >> 17286241

In vitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents.

Pulok Kumar Mukherjee1, Venkatesan Kumar, Mainak Mal, Peter J Houghton.   

Abstract

The in vitro acetylcholinesterase (AChE) inhibitory potential of the hydroalcoholic extract and of the essential oil from Acorus calamus (AC) rhizomes and that of its major constituents were evaluated based on the Ellman's method. GC/MS analysis of the oil revealed that the major constituents were beta-asarone (79.54%) and alpha-asarone (8.47%). The IC50 values were obtained for the hydroalcoholic extract, the essential oil, beta-asarone and alpha-asarone and were 182.31+/-16.78 microg/mL, 10.67+/-0.81 microg/mL, 3.33+/-0.02 microM and 46.38+/-2.69 microM, respectively. Physostigmine was used as standard inhibitor with an IC50 value of 0.28+/-0.015 microM. The experimental observations revealed that the AC essential oil and its constituents have significant AChE inhibitory potential. beta-Asarone, the major phytoconstituent present in the essential oil, showed the maximum inhibitory potential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286241     DOI: 10.1055/s-2007-967114

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  17 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Chemical composition, aroma evaluation, and inhibitory activity towards acetylcholinesterase of essential oils from Gynura bicolor DC.

Authors:  Mitsuo Miyazawa; Hiroshi Nakahashi; Atsushi Usami; Naoki Matsuda
Journal:  J Nat Med       Date:  2016-01-12       Impact factor: 2.343

3.  Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes.

Authors:  Alexander T Cartus; Dieter Schrenk
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-05       Impact factor: 3.000

Review 4.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Ligand-based virtual screening, molecular docking, and molecular dynamics of eugenol analogs as potential acetylcholinesterase inhibitors with biological activity against Spodoptera frugiperda.

Authors:  Domingo Méndez-Álvarez; Verónica Herrera-Mayorga; Alfredo Juárez-Saldivar; Alma D Paz-González; Eyra Ortiz-Pérez; Debasish Bandyopadhyay; Horacio Pérez-Sánchez; Gildardo Rivera
Journal:  Mol Divers       Date:  2021-09-16       Impact factor: 3.364

Review 6.  Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy.

Authors:  Ashwani Arya; Rubal Chahal; Rekha Rao; Md Habibur Rahman; Deepak Kaushik; Muhammad Furqan Akhtar; Ammara Saleem; Shaden M A Khalifa; Hesham R El-Seedi; Mohamed Kamel; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Vineet Mittal
Journal:  Biomolecules       Date:  2021-02-25

7.  Nootropic herbs (Medhya Rasayana) in Ayurveda: An update.

Authors:  Reena Kulkarni; K J Girish; Abhimanyu Kumar
Journal:  Pharmacogn Rev       Date:  2012-07

8.  Anticonvulsant activity of raw and classically processed Vacha (Acorus calamus Linn.) rhizomes.

Authors:  Savitha D Bhat; B K Ashok; R N Acharya; B Ravishankar
Journal:  Ayu       Date:  2012-01

9.  The Dual Antimelanogenic and Antioxidant Activities of the Essential Oil Extracted from the Leaves of Acorus macrospadiceus (Yamamoto) F. N. Wei et Y. K. Li.

Authors:  Huey-Chun Huang; Hsiao-Fen Wang; Kuang-Hway Yih; Long-Zen Chang; Tsong-Min Chang
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-31       Impact factor: 2.629

10.  Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant α-asarone.

Authors:  Ze-Jun Wang; Simon R Levinson; Liqin Sun; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2014-03-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.